(Q35121627)

English

A recombinant modified vaccinia ankara vaccine encoding Epstein-Barr Virus (EBV) target antigens: a phase I trial in UK patients with EBV-positive cancer

scientific article

Statements

A recombinant modified vaccinia ankara vaccine encoding Epstein-Barr Virus (EBV) target antigens: a phase I trial in UK patients with EBV-positive cancer (English)
14 August 2014

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit